NCT06486987

Brief Summary

The CHAMP-T2 study is a pilot test of the efficacy of constraint induced movement therapy (CIMT) when delivered by tele-video in the child's home or home-like environment. This study will examine the pre-, post-intervention function a hemiparetic limb in children who have hemiplegic cerebral palsy. The purpose is to provide an effect size estimate that will inform the design of a future study that will compare tele-delivered CIMT with usual and customary care.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
14mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Jun 2024Jun 2027

First Submitted

Initial submission to the registry

June 27, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

June 27, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 5, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

2.5 years

First QC Date

June 27, 2024

Last Update Submit

December 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Melbourne Assessment of Unilateral Upper Limb Function

    Measures function of the impaired upper limb

    At baseline pre-treatment and at the end of the 4-week intervention

Secondary Outcomes (3)

  • Assisting Hand Assessment

    At baseline pre-treatment and at the end of the 4-week intervention

  • Pediatric Motor Activity Log

    At baseline pre-treatment and at the end of the 4-week intervention

  • Fidelity to treatment protocol

    During 4 weeks of intervention

Study Arms (1)

Intervention arm

EXPERIMENTAL

This is a single arm in an open label pre- post-treatment design to estimate effect size of the intervention

Other: Constraint induced movement therapy delivered by televideo

Interventions

In-home Constraint induced movement therapy delivered by a therapist participating by televideo

Intervention arm

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children who have hemiplegic cerebral palsy, ages 4-10;
  • hemiparesis ranging from Manual Ability Classification System (MACS) I to MACS IV;
  • live within a 1.5 hour distance from therapists' worksites at the Ohio State University Wexner Medical Center in Columbus, Ohio, or the Fralin Biomedical Research Institute in Roanoke, Virginia;
  • are willing to travel to these sites for two in-person assessments.

You may not qualify if:

  • Previous high dose CIMT (defined as CIMT given 2 hrs per day for 10 days) in the 6 months preceding baseline assessment;
  • Treatment with botulinum toxin for spasticity in the 3 months preceding baseline assessment;
  • Surgery for spasticity in the 6 months preceding baseline assessment;
  • Medically unstable and unable to participate in the treatment intervention;
  • Child is behaviorally or cognitively impaired so unable to participate in the treatment intervention;
  • Family unable to participate in tele-delivery of CIMT 5 days a week for 4 weeks;
  • the caregiver available at child's treatment site during treatment times is unable to communicate with the treating therapist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Ohio State University School of Health and Rehabilitation Sciences

Columbus, Ohio, 43210, United States

Location

Virginia Tech-Fralin Biomedical Research Institute

Roanoke, Virginia, 24016, United States

Location

Related Publications (1)

  • Ramey SL, DeLuca SC, Stevenson RD, Conaway M, Darragh AR, Lo W; CHAMP. Constraint-Induced Movement Therapy for Cerebral Palsy: A Randomized Trial. Pediatrics. 2021 Nov;148(5):e2020033878. doi: 10.1542/peds.2020-033878. Epub 2021 Oct 14.

    PMID: 34649982BACKGROUND

Study Officials

  • Warren Lo, MD

    Nationwide Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Participants with hemiplegic cerebral palsy will be treated with constraint induced movement therapy with the therapist participating by televideo
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor, Pediatrics and Neurology

Study Record Dates

First Submitted

June 27, 2024

First Posted

July 5, 2024

Study Start

June 27, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 30, 2027

Last Updated

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

For this small pilot study we do not anticipate sharing individual participant data because of the difficulty of maintain subject confidentiality

Locations